Search

everythinglearnresearchcommunity

for

Search:↓

Cronkhite-Canada syndrome is a rare condition causing gut polyps, hair loss, skin changes, and nail issues, often with a poor outlook.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Clinicians can use vibe coding to easily engage in machine learning research without needing to know Python.

Blunt cannula lip fillers are safe, effective, and comfortable, with no bruising.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Combining subcision, PRP, and microneedling effectively treats acne scars with minimal side effects.

Some canine hair follicle tumors contain amyloid deposits, with a protein called CK5 involved in their formation.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.

Combining cantigi and henna leaf extracts boosts antioxidant activity.

Daily use of CBD-rich hemp oil significantly increased hair growth in people with hair loss.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

A boy's scalp rash and baldness were cured using oral medication and medicated shampoo.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Hair loss during breast cancer treatment affects each woman differently, influenced by her environment and family.

Breast cancer alters specific molecular structures in hair, which revert after cancer removal.

Two patients with Cronkhite-Canada syndrome achieved remission after treatment.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

An 80-year-old woman with Cronkhite-Canada syndrome had multiple polyps and symptoms like diarrhea, hair loss, nail issues, and dark skin.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

A red fox with skin lesions was cured of a fungal infection after treatment.

Malignant melanoma is the deadliest skin cancer, while BCC is the most common but rarely spreads, and SCC is more aggressive than BCC.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.